SEC Form 4 · accession 0001209191-15-001754
HARVARD BIOSCIENCE INC · HBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Jeffrey Duchemin
Officer — Chief Executive Officer · Director
Period of report
Dec 31, 2014
Accepted (ET)
Jan 5, 2015 · 9:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001123494
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Dec 31, 2014 | J | 3,366 | $4.00 | A | 6,374 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares acquired under the Issuer's Employee Stock Purchase Plan.
- F2Represents the purchase price for each share purchased under the Employee Stock Purchase Plan and equals 85% of the fair market value of the common stock on July 1, 2014, being the offering date under the plan.
Remarks
This form is signed under power of attorney.